ArradiCAN - Layout - Review
-
Layout: Sizing of images and font should be revised. Images on the left are too large, the indication is too small relative to the claim.
Layout: We question the use of before and after images, especially the time difference between images which implies longevity, efficacy, and improved quality of life which is misleading and unsubstantiated. The use of colours and family/friends creates a misleading separation too. (s2.6.1)
Layout: Please increase the font size of the indication relative to the first claim.
Layout: Please use the correct graph. This one is product vs. placebo, not product vs. chemotherapy. Or provide a reference and include it in the copy deck.
Layout: Please remove the arrow from the second graph. This overemphasizes the relative risk and alludes to a direction which may be misleading. Please consider an alternative shape.
Layout: Please reduce the font size of the MOA and safety claim so that they are within 75% of the fair balance. Also please increase fair balance so that it is within 75% of the largest claim copy.
Layout: Please provide a reference to support the claim that this product is new and include it in the copy deck.
Layout: Upon renewal of this eFile, you will be required to remove “New”.Layout: Please decrease the size and move down of the PSP design as it is overemphasized. Its presence amongst product information is misleading. Claims about the program cannot be applied to the product.
Layout: Please ensure that MOA and safety/efficacy information are separate.